AlphaStocks
4.7
Weak

CME Group Inc. (CME)

As of Sep 20, 2026, CME Group Inc. (CME) scores 4.7/10 on AlphaStocks' five-model composite, #201 of 265 Financials stocks. At $276, CME trades 25% above its model fair value of $222.

Financials / Financial Exchanges & Data

S&P 500

$276.02

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#201out of 265 in Financials

Is CME GROUP INC. a Good Investment in 2026?

CME GROUP INC. (CME) scores 4.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates CME GROUP INC. as Strong. The Graham model is the least favorable, rating it Neutral. CME GROUP INC. currently trades 25% above its estimated fair value of $222. CME GROUP INC. ranks #201 out of 265 stocks in the Financials sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.4ROE14.3Market Cap100BDiv Yield4.5

Estimated Fair Value

$221.5325% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/8

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

88% above fair value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Attractive

Earnings yield 5.1% · ROC 78%

Frequently Asked Questions

Is CME GROUP INC. (CME) a good investment?
As of Sep 20, 2026, CME Group Inc. (CME) scores 4.7/10 on AlphaStocks' five-model composite, #201 of 265 Financials stocks. At $276, CME trades 25% above its model fair value of $222. That score is below average, suggesting caution.
What is CME GROUP INC.'s Piotroski F-Score?
CME GROUP INC.'s Piotroski F-Score status is Attractive. The raw score is 6/8. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CME overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $222, CME appears overvalued. The stock currently trades 25% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does CME compare to other Financials stocks?
CME GROUP INC. ranks #201 out of 265 stocks in the Financials sector, placing it in the top 76% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CME?
AlphaStocks evaluates CME using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.7/10.

Similar Stocks

Compare CME with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer